1 |
Luo, X. J. and Zhang, C. 2016. Down-regulation of SIRT1 gene expression in major depressive disorder. Am. J. Psychiatry 173, 1046.
DOI
|
2 |
Malykhin, N. V. and Coupland, N. J. 2015. Hippocampal neuroplasticity in major depressive disorder. Neuroscience 309, 200-213.
DOI
|
3 |
Michan, S. and Sinclair, D. 2007. Sirtuins in mammals: insights into their biological function. Biochem. J. 404, 1-13.
DOI
|
4 |
Nakahata, Y., Kaluzova, M., Grimaldi, B., Sahar, S., Hirayama, J., Chen, D., Guarente, L. P. and Sassone-Corsi, P. 2008. The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 134, 329-340.
DOI
|
5 |
O'Connor, J. C., Lawson, M. A., Andre, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W. and Dantzer, R. 2009. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol. Psychiatry 14, 511-522.
DOI
|
6 |
Ozawa, H., Miyagawa, S., Fukushima, S., Itoh, E., Harada, A., Saito, A., Ueno, T., Toda, K., Kuratani, T. and Sawa, Y. 2016. Sirtuin1 regulates the stem cell therapeutic effects on regenerative capability for treating severe heart failure in a juvenile animal model. Ann. Thorac. Surg. 102, 803-812.
DOI
|
7 |
Chang, H. C. and Guarente, L. 2013. SIRT1 mediates central circadian control in the SCN by a mechanism that decays with aging. Cell 153, 1448-1460.
DOI
|
8 |
CONVERGE consortium. 2015. Sparse whole-genome sequencing identifies two loci for major depressive disorder. Nature 523, 588-591.
DOI
|
9 |
Duman, R. S. and Aghajanian, G. K. 2012. Synaptic dysfunction in depression: potential therapeutic targets. Science 338, 68-72.
DOI
|
10 |
Dwivedi, Y., Rizavi, H. S., Roberts, R. C., Conley, R. C., Tamminga, C. A. and Pandey, G. N. 2001. Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J. Neurochem. 77, 916-928.
DOI
|
11 |
Gao, J., Wang, W. Y., Mao, Y. W., Graff, J., Guan, J. S., Pan, L., Mak, G., Kim, D., Su, S. C. and Tsai, L. H. 2010. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 466, 1105-1109.
DOI
|
12 |
Ali, S. H., Madhana, R. M., K. V. A., Kasala, E. R., Bodduluru, L. N., Pitta, S., Mahareddy, J. R. and Lahkar, M. 2015. Resveratrol ameliorates depressive-like behavior in repeated corticosterone-induced depression in mice. Steroids 101, 37-42.
DOI
|
13 |
Piccinni, A., Marazziti, D., Catena, M., Domenici, L., Del Debbio, A., Bianchi, C., Mannari, C., Martini, C., Da Pozzo, E., Schiavi, E., Mariotti, A., Roncaglia, I., Palla, A., Consoli, G., Giovannini, L., Massimetti, G. and Dell'Osso, L. 2008. Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J. Affect. Disord. 105, 279-283.
DOI
|
14 |
Price, J. L. and Drevets, W. C. 2010. Neurocircuitry of mood disorders. Neuropsychopharmacology 35, 192-216.
DOI
|
15 |
Lucassen, P. J., Oomen, C. A., Naninck, E. F., Fitzsimons, C. P., van Dam, A. M., Czeh, B. and Korosi, A. 2015. Regulation of adult neurogenesis and plasticity by (Early) stress, glucocorticoids, and inflammation. Cold Spring Harb. Perspect. Biol. 7, a021303.
DOI
|
16 |
Huhtiniemi, T., Wittekindt, C., Laitinen, T., Leppanen, J., Salminen, A., Poso, A. and Lahtela-Kakkonen, M. 2006. Comparative and pharmacophore model for deacetylase SIRT1. J. Comput. Aided. Mol. Des. 20, 589-599.
DOI
|
17 |
Lee, I. H., Cao, L., Mostoslavsky, R., Lombard, D. B., Liu, J., Bruns, N. E., Tsokos, M., Alt, F. W. and Finkel, T. 2008. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc. Natl. Acad. Sci. USA. 105, 3374-3379.
DOI
|
18 |
Li, N., Lee, B., Liu, R. J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X. Y., Aghajanian, G. and Duman, R. S. 2010. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329, 959-964.
DOI
|
19 |
Iniguez, S. D., Vialou, V., Warren, B. L., Cao, J. L., Alcantara, L. F., Davis, L. C., Manojlovic, Z., Neve, R. L., Russo, S. J., Han, M. H., Nestler, E. J. and Bolanos-Guzman, C. A. 2010. Extracellular signal-regulated kinase-2 within the ventral tegmental area regulates responses to stress. J. Neurosci. 30, 7652-7663.
DOI
|
20 |
Akinfiresoye, L. and Tizabi, Y. 2013. Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR. Psychopharmacology (Berl) 230, 291-298.
DOI
|
21 |
Balu, D. T., Hoshaw, B. A., Malberg, J. E., Rosenzweig-Lipson, S., Schechter, L. E. and Lucki, I. 2008. Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments. Brain Res. 1211, 37-43.
DOI
|
22 |
Kovanen, L., Donner, K. and Partonen, T. 2015. SIRT1 Polymorphisms Associate with seasonal weight variation, depressive disorders, and diastolic blood pressure in the general population. PLoS One 10, e0141001.
DOI
|
23 |
Hurley, L. L., Akinfiresoye, L., Kalejaiye, O. and Tizabi, Y. 2014. Antidepressant effects of resveratrol in an animal model of depression. Behav. Brain Res. 268, 1-7.
DOI
|
24 |
Impey, S., Obrietan, K. and Storm, D. R. 1999. Making new connections: role of ERK/MAP kinase signaling in neuronal plasticity. Neuron 23, 11-14.
DOI
|
25 |
Tonkin, J., Villarroya, F., Puri, P. L. and Vinciguerra, M. 2012. SIRT1 signaling as potential modulator of skeletal muscle diseases. Curr. Opin. Pharmacol. 12, 372-376.
DOI
|
26 |
Wang, H., Xu, Y., Yan, J., Zhao, X., Sun, X., Zhang, Y., Guo, J. and Zhu, C. 2009. Acteoside protects human neuroblastoma SH-SY5Y cells against beta-amyloid-induced cell injury. Brain Res. 1283, 139-147.
DOI
|
27 |
Kaeberlein, M., McVey, M. and Guarente, L. 1999. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 13, 2570-2580.
DOI
|
28 |
Kishi, T., Yoshimura, R., Kitajima, T., Okochi, T., Okumura, T., Tsunoka, T., Yamanouchi, Y., Kinoshita, Y., Kawashima, K., Fukuo, Y., Naitoh, H., Umene-Nakano, W., Inada, T., Nakamura, J., Ozaki, N. and Iwata, N. 2010. SIRT1 gene is associated with major depressive disorder in the Japanese population. J. Affect. Disord. 126, 167-173.
DOI
|
29 |
Kodali, M., Parihar, V. K., Hattiangady, B., Mishra, V., Shuai, B. and Shetty, A. K. 2015. Resveratrol prevents age-related memory and mood dysfunction with increased hippocampal neurogenesis and microvasculature, and reduced glial activation. Sci. Rep. 5, 8075.
DOI
|
30 |
Brochier, C., Dennis, G., Rivieccio, M. A., McLaughlin, K., Coppola, G., Ratan, R. R. and Langley, B. 2013. Specific acetylation of p53 by HDAC inhibition prevents DNA damage-induced apoptosis in neurons. J. Neurosci. 33, 8621-8632.
DOI
|
31 |
Abe-Higuchi, N., Uchida, S., Yamagata, H., Higuchi, F., Hobara, T., Hara, K., Kobayashi, A. and Watanabe, Y. 2016. Hippocampal Sirtuin 1 signaling mediates depression-like behavior. Biol. Psychiatry 80, 815-826.
DOI
|
32 |
Renthal, W., Kumar, A., Xiao, G., Wilkinson, M., Covington, H. E. 3rd., Maze, I., Sikder, D., Robison, A. J., LaPlant, Q., Dietz, D. M., Russo, S. J., Vialou, V., Chakravarty, S., Kodadek, T. J., Stack, A., Kabbaj, M. and Nestler, E. J. 2009. Genome-wide analysis of chromatin regulation by cocaine reveals a role for sirtuins. Neuron 62, 335-348.
DOI
|
33 |
Kwon, H. S. and Ott, M. 2008. The ups and downs of SIRT1. Trends Biochem. 33, 517-525.
DOI
|
34 |
Sarkisova, K. and van Luijtelaar, G. 2011. The WAG/Rij strain: a genetic animal model of absence epilepsy with comorbidity of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 854-876.
|
35 |
Sauve, A. A, Wolberger, C., Schramm, V. L. and Boeke, J. D. 2006. The biochemistry of sirtuins. Annu. Rev. Biochem. 75, 435-465.
DOI
|
36 |
Masi, G. and Brovedani, P. 2011. The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression. CNS Drugs 25, 913-931.
DOI
|
37 |
McEwen, B. S., Eiland, L., Hunter, R. G. and Miller, M. M. 2012. Stress and anxiety: structural plasticity and epigenetic regulation as a consequence of stress. Neuropharmacology 62, 3-12.
DOI
|
38 |
Michan, S., Li, Y., Chou, M. M., Parrella, E., Ge, H., Long, J. M., Allard, J. S., Lewis, K., Miller, M., Xu, W., Mervis, R. F., Chen, J., Guerin, K. I., Smith, L. E., McBurney, M. W., Sinclair, D. A., Baudry, M., de Cabo, R. and Longo, V. D. 2010. SIRT1 is essential for normal cognitive function and synaptic plasticity. J. Neurosci. 30, 9695-9707.
DOI
|
39 |
Nakahata, Y., Sahar, S., Astarita, G., Kaluzova, M. and Sassone-Corsi, P. 2009. Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science 324, 654-657.
DOI
|
40 |
Nivoli, A., Porcelli, S., Albani, D., Forloni, G., Fusco, F., Colom, F., Vieta, E. and Serretti, A. 2016. Association between Sirtuin 1 gene rs10997870 polymorphism and suicide behaviors in bipolar disorder. Neuropsychobiology 74, 1-7.
DOI
|
41 |
Albrecht, U. 2013. Circadian clocks and mood-related behaviors. Handb. Exp. Pharmacol. 217, 227-239.
DOI
|
42 |
Albrecht, U. 2017. Molecular mechanisms in mood regulation involving the circadian clock. Front. Neurol. 8, 30.
DOI
|
43 |
Wirz-Justice, A. 2006. Biological rhythm disturbances in mood disorders. Int. Clin. Psychopharmacol. 21, S11-S15.
DOI
|
44 |
Duric, V., Banasr, M., Licznerski, P., Schmidt, H. D., Stockmeier, C. A., Simen, A. A., Newton, S. S. and Duman, R. S. 2010. A negative regulator of MAP kinase causes depressive behavior. Nat. Med. 16, 1328-1332.
DOI
|
45 |
Ge, L., Liu, L., Liu, H., Liu, S., Xue, H., Wang, X., Yuan, L., Wang, Z. and Liu, D. 2015. Resveratrol abrogates lipopolysaccharide-induced depressive-like behavior, neuroinflammatory response, and CREB/BDNF signaling in mice. Eur. J. Pharmacol. 768, 49-57.
DOI
|
46 |
Ozawa, Y., Kubota, S., Narimatsu, T., Yuki, K., Koto, T., Sasaki, M. and Tsubota, K. 2010. Retinal aging and sirtuins. Ophthalmic Res. 44, 199-203.
DOI
|
47 |
Ramadori, G., Fujikawa, T., Anderson, J., Berglund, E. D., Frazao, R., Michan, S., Vianna, C. R., Sinclair, D. A., Elias, C. F. and Coppari, R. 2011. SIRT1 deacetylase in SF1 neurons protects against metabolic imbalance. Cell Metab. 14, 301-312.
DOI
|
48 |
Wang, R., Zhang, Y., Li, J. and Zhang, C. 2017. Resveratrol ameliorates spatial learning memory impairment induced by Abeta(1-42) in rats. Neuroscience 344, 39-47.
DOI
|
49 |
Li, Y., Xu, W., McBurney, M. W. and Longo, V. D. 2008. SirT1 inhibition reduces IGF-I/IRS-2/Ras/ERK1/2 signaling and protects neurons. Cell Metab. 8, 38-48.
DOI
|
50 |
Winder, D. G., Martin, K. C., Muzzio, I. A., Rohrer, D., Chruscinski, A., Kobilka, B. and Kandel, E. R. 1999. ERK plays a regulatory role in induction of LTP by theta frequency stimulation and its modulation by beta-adrenergic receptors. Neuron 24, 715-726.
DOI
|
51 |
Wojcik, M., Mac-Marcjanek, K. and Wozniak, L. A. 2009. Physiological and pathophysiological functions of SIRT1. Mini Rev. Med. Chem. 9, 386-394.
DOI
|
52 |
Yang, Y., Fu, W., Chen, J., Olashaw, N., Zhang, X., Nicosia, S. V., Bhalla, K. and Bai, W. 2007. SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress. Nat. Cell Biol. 9, 1253-1262.
DOI
|
53 |
Yirmiya, R., Rimmerman, N. and Reshef, R. 2015. Depression as a microglial disease. Trends Neurosci. 38, 637-658.
DOI
|
54 |
Zarate, C. A. Jr., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S. and Manji, H. K. 2006. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry 63, 856-864.
DOI
|
55 |
Duman, C. H., Schlesinger, L., Kodama, M., Russell, D. S. and Duman, R. S. 2007. A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol. Psychiatry 61, 661-670.
DOI
|
56 |
Hayley, S. and Litteljohn, D. 2013. Neuroplasticity and the next wave of antidepressant strategies. Front. Cell Neurosci. 7, 218.
DOI
|
57 |
Mimura, T., Kaji, Y., Noma, H., Funatsu, H. and Okamoto, S. 2013. The role of SIRT1 in ocular aging. Exp. Eye Res. 116, 17-26.
DOI
|
58 |
Libert, S., Pointer, K., Bell, E. L., Das, A., Cohen, D. E., Asara, J. M., Kapur, K., Bergmann, S., Preisig, M., Otowa, T., Kendler, K. S., Chen, X., Hettema, J. M., van den Oord, E. J., Rubio, J. P. and Guarente, L. 2011. SIRT1 activates MAO-A in the brain to mediate anxiety and exploratory drive. Cell 147, 1459-1472.
DOI
|
59 |
Cohen, D. E., Supinski, A. M., Bonkowski, M. S., Donmez, G. and Guarente, L. P. 2009. Neuronal SIRT1 regulates endocrine and behavioral responses to calorie restriction. Genes Dev. 23, 2812-2817.
DOI
|
60 |
Corpas, R., Revilla, S., Ursulet, S., Castro-Freire, M., Kaliman, P., Petegnief, V., Gimenez-Llort, L., Sarkis, C., Pallas, M. and Sanfeliu, C. 2017. SIRT1 overexpression in mouse hippocampus induces cognitive enhancement through proteostatic and neurotrophic mechanisms. Mol. Neurobiol. 54, 5604-5619.
DOI
|
61 |
Duman, R. S. and Voleti, B. 2012. Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents. Trends Neurosci. 35, 47-56.
DOI
|
62 |
Alonso, M., Melani, M., Converso, D., Jaitovich, A., Paz, C., Carreras, M. C., Medina, J. H. and Poderoso, J. J. 2004. Mitochondrial extracellular signal-regulated kinases 1/2 (ERK1/2) are modulated during brain development. J. Neurochem. 89, 248-256.
DOI
|
63 |
Asher, G., Gatfield, D., Stratmann, M., Reinke, H., Dibner, C., Kreppel, F., Mostoslavsky, R., Alt, F. W. and Schibler, U. 2008. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 134, 317-328.
DOI
|
64 |
Ferland, C. L. and Schrader, L. A. 2011. Regulation of histone acetylation in the hippocampus of chronically stressed rats: a potential role of sirtuins. Neuroscience 174, 104-114.
DOI
|
65 |
Brummelte, S., Pawluski, J. L. and Galea, L. A. 2006. High post-partum levels of corticosterone given to dams influence postnatal hippocampal cell proliferation and behavior of offspring: A model of post-partum stress and possible depression. Horm. Behav. 50, 370-382.
DOI
|
66 |
Codocedo, J. F., Allard, C., Godoy, J. A., Varela-Nallar, L. and Inestrosa, N. C. 2012. SIRT1 regulates dendritic development in hippocampal neurons. PLoS One 7, e47073.
DOI
|
67 |
Ferland, C. L., Hawleym, W. R., Puckettm, R. E., Winebergm, K., Lubinm, F. D., Dohanichm, G. P. and Schrader, L. A. 2013. Sirtuin activity in dentate gyrus contributes to chronic stress- induced behavior and extracellular signal-regulated protein kinases 1 and 2 cascade changes in the hippocampus. Biol. Psychiatry 74, 927-935 .
DOI
|
68 |
Han, J., Hubbard, B. P., Lee, J., Montagna, C., Lee, H. W., Sinclair, D. A. and Suh, Y. 2013. Analysis of 41 cancer cell lines reveals excessive allelic loss and novel mutations in the SIRT1 gene. Cell Cycle 12, 263-270.
DOI
|
69 |
Liu, L., Zhang, Q., Cai, Y., Sun, D., He, X., Wang, L., Yu, D., Li, X., Xiong, X., Xu, H., Yang, Q. and Fan, X. 2016. Resveratrol counteracts lipopolysaccharide-induced depressive-like behaviors via enhanced hippocampal neurogenesis. Oncotarget 7, 56045-56059.
DOI
|
70 |
Lopez, A. D. and Mathers, C. D. 2006. Measuring the global burden of disease and epidemiological transitions: 2002-2030. Ann. Trop. Med. Parasitol. 100, 481-499.
DOI
|
71 |
Seo, M. K., Kim, H. K., Baek, S. Y., Lee, J. G., Urm, S. H., Park, S. W. and Seog, D. H. 2021. A study on the effects of sirtuin 1 on dendritic outgrowth and spine formation and mechanism in neuronal cells. J. Life Sci. 9, 806-817.
|